Table 1.
Variable | N | TXNDC17 expression | P value | |
---|---|---|---|---|
Low | High | |||
Age(years) | 0.192 | |||
<50 | 66 | 41 | 25 | |
≥50 | 91 | 47 | 44 | |
FIGO stage | 0.076 | |||
I/II | 33 | 23 | 10 | |
III/IV | 124 | 65 | 59 | |
Tumor grade | 0.615 | |||
I/II | 58 | 31 | 27 | |
III | 99 | 57 | 42 | |
Ascitic fluid volume (mL) | 0.066 | |||
<500 | 99 | 61 | 38 | |
≥500 | 58 | 27 | 31 | |
Serum CA125(U/mL) | 0.017* | |||
<500 | 76 | 50 | 26 | |
≥500 | 81 | 38 | 43 | |
Primary surgery | 0.010* | |||
Optimal | 114 | 71 | 43 | |
Suboptimal | 43 | 17 | 26 | |
Chemosensitivity | 0.007** | |||
Sensitive | 117 | 75 | 42 | |
Resistant | 34 | 13 | 21 | |
BECN1 expression | 0.000** | |||
Low | 99 | 77 | 22 | |
High | 58 | 11 | 47 |
* P < 0.05, ** P < 0.01